Related Experiment Videos

Vitamin D-binding protein in the perinatal period

Insights

Serum vitamin D-binding protein (DBP) levels increase with fetal age and are not affected by phenotype. No DBP abnormalities were found in hypocalcemic newborns.

Area of Science:

  • Biochemistry
  • Neonatology
  • Genetics

Background:

  • Serum vitamin D-binding protein (DBP) is crucial for vitamin D transport.
  • Understanding DBP levels in newborns is important for assessing calcium homeostasis.
  • Gestational age and clinical conditions can potentially influence DBP levels.

Purpose of the Study:

  • To investigate the molecular polymorphism and quantitative levels of serum DBP in preterm, full-term, and hypocalcemic newborn infants.
  • To determine the relationship between DBP levels, phenotype, and gestational age.
  • To assess if DBP abnormalities are associated with neonatal hypocalcemia.

Main Methods:

  • Serum samples were collected from preterm, full-term, and hypocalcemic newborn infants.
  • Molecular polymorphism of DBP was analyzed.
  • Quantitative levels of serum DBP were measured.
  • Statistical analysis was performed to correlate DBP levels with gestational age, phenotype, and clinical status.

Main Results:

  • Serum DBP concentration increases with fetal age from 32-33 weeks to 35 weeks of gestation.
  • DBP serum concentration is not influenced by DBP phenotype.
  • No significant differences in DBP allele distribution or quantitative levels were observed in 29 hypocalcemic full-term newborn infants.

Conclusions:

  • Serum DBP levels demonstrate a developmental trajectory during late gestation.
  • DBP phenotype does not appear to affect serum DBP concentrations in newborns.
  • Neonatal hypocalcemia in full-term infants is not associated with altered DBP allele distribution or quantitative levels.

Related Concept Videos